Market Research Logo

Global Intravenous Immunoglobulins Market 2017-2021

Global Intravenous Immunoglobulins Market 2017-2021

About Intravenous Immunoglobulins

Immunoglobulins are glycoprotein molecules produced by plasma cells. They are a critical part of a body's immune response and they do so by specifically recognizing and binding to microbes and destroying them. These immunoglobulins are produced by a body naturally, but due to some genetic or infectious diseases, the natural production of immunoglobulin is inhibited, resulting in an immune-compromised condition.

Technavio’s analysts forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • CSL Behring
  • Grifols
  • Octapharma
  • Shire
Other prominent vendors
  • ADMA Biologics
  • Bayer
  • Bharat Serum and Vaccines
  • Biotest AG
  • China Biologic Products
  • Hualan Biological Engineering
  • Kedrion Biopharma
  • LFB Group
  • Sanquin
Market driver
  • Growing number of fractionating units
  • For a full, detailed list, view our report
Market challenge
  • Complex and cost-intensive manufacturing
  • For a full, detailed list, view our report
Market trend
  • Monetary support to plasma donors
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Intravenous Immunoglobulins Market 2017-2021

Technavio recognizes the following companies as the key players in the global intravenous immunoglobulins market: CSL Behring, Grifols, Octapharma, and Shire.

Other Prominent Vendors in the market are: ADMA Biologics, Bayer, Bharat Serum and Vaccines, Biotest AG, China Biologic Products, Hualan Biological Engineering, Kedrion Biopharma, LFB Group, and Sanquin.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is monetary support to plasma donors. The intravenous immunoglobulin market is growing at steady rate, where the number of plasma donors affects the overall supply chain. Therefore, to maintain and meet the demands of plasma-derived therapeutics, a plasma donor receives monetary compensation.”

According to the report, one driver in the market is growing number of fractionating units. Fractionation is a crucial step in the manufacture of immunoglobulins. This step involves separation of immunoglobulins and other blood protein from plasma. The capacity of fractionating units is increasing. Data estimates suggest that during 2013-2016, the capacity increased by 39.5%. This increased capacity is primarily due to the installment of new fractionating units or expansion of existing fractionating units.

Further, the report states that one challenge in the market is complex and cost-intensive manufacturing. Immunoglobulin manufacturing involves complex, time and cost consuming stages. The process starts from collection of plasma from volunteers. It is followed by plasma fractionation coupled with virus and prion removals. This step is followed by in-vitro testing, which ensures the safety, efficacy and potency of manufactured immunoglobulin.

CSL Behring, Grifols, Octapharma, Shire, ADMA Biologics, Bayer, Bharat Serum and Vaccines, Biotest AG, China Biologic Products, Hualan Biological Engineering, Kedrion Biopharma, LFB Group, and Sanquin.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
  • An overview of diseases treated using intravenous immunoglobulins
    • Table Major diseases treated using intravenous immunoglobins therapy
  • Market landscape
    • Market overview
      • Table Global intravenous immunoglobulins market snapshot
      • Table Global intravenous immunoglobins market 2016-2021 ($ millions)
      • Table Opportunity analysis in global intravenous immunoglobulins market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline analysis of vendors
    • Table Key clinical trials 2016
  • Market segmentation by Therapy area
    • Table Global intravenous immunoglobulin market by therapy area 2016
    • Global intravenous immunoglobulins market by neurology
      • Table Global intravenous immunoglobins market for neurology 2016-2021 ($ million)
    • Global intravenous immunoglobins market for hematology
      • Table Global intravenous immunoglobins market by hematology 2016-2021 ($ million)
    • Global intravenous immunoglobins market for immunology
      • Table Global intravenous immunoglobins market for immunology 2016-2021 ($ million)
    • Global intravenous immunoglobins market for others
      • Table Global intravenous immunoglobins market for others 2016-2021 ($ million)
  • Geographical segmentation
    • Table Global intravenous immunoglobulin market by geography 2016 and 2021
    • Table Global intravenous immunoglobulin market by geography 2016-2021 ($ millions)
    • Intravenous immunoglobulins market in Americas
      • Table Market scenario in Americas
      • Table Intravenous immunoglobulins market in Americas 2016-2021 ($ millions)
      • Table North America: Percentage of global fractionation capacities 1999-2012
    • Intravenous immunoglobulins market in EMEA
      • Table Market Scenario in EMEA
      • Table Intravenous immunoglobulins market in EMEA 2016-2021 ($ million)
      • Table Europe: percentage of global fractionation capacities 1999-2012
    • Intravenous immunoglobulins market in APAC
      • Table Market Scenario in APAC
      • Table Intravenous immunoglobulins market in APAC 2016-2021 ($ million)
      • Table APAC: Percentage of global fractionation capacities 1999-2012
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Fractionation capacities of key vendors
    • Market challenges
      • Table Factors contributing to overall cost of immunoglobulin production
      • Table Various side-effects associated with immunoglobulin therapy
      • Table Regulatory requirements for TGA approval
  • Market trends
    • Shift in manufacturing facilities to low-cost regions
      • Table Fractionating capacities globally 2007 and 2012
    • Monetary support to plasma donors
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global intravenous immunoglobulins market 2016
      • Table Competitive factors in global intravenous immunoglobulins market
      • Table Market penetration of manufacturers of intravenous immunoglobulins worldwide 2016
      • Table Strategic success factors of companies in global intravenous immunoglobulins market
      • Table Key news in IVIG market
  • Key vendor analysis
    • CSL Behring
      • Table CSL Behring: Key Highlights
      • Table CSL Behring: Strength assessment
      • Table CSL Behring: Strategy assessment
      • Table CSL Behring: Opportunity assessment
    • Grifols
      • Table Grifols: Key highlights
      • Table Grifols: Strength assessment
      • Table Grifols: Strategy assessment
      • Table Grifols: Opportunity assessment
    • Octapharma
      • Table Octapharma: Key highlights
      • Table Octapharma: Strength assessment
      • Table Octapharma: Strategy assessment
      • Table Octapharma: Opportunity assessment
    • Shire
      • Table Shire: Key highlights
      • Table Shire: Strength assessment
      • Table Shire: Strategy assessment
      • Table Shire: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report